Showing results (1-10 of 3,828) with videos related to
Sort By:
Pageof 383
World Journal of Clinical Cases|November 17, 2021
Tricuspid valve endocarditis: Cardiovascular imaging evaluation and managementAgostina M Fava, Bo XuEchocardiography (Mount Kisco, N.Y.)|May 18, 2023
Prominent para-cardiac fat mimicking left atrial appendage thrombus on echocardiography: Utility of cardiac computed tomographyBianca Honnekeri, Agostina M Fava, Reza Reyaldeen, et al.The American Journal of Cardiology|September 22, 2024
Diastolic Stress Echocardiography in Patients With Hypertrophy Cardiomyopathy: Association With Exercise CapacityAgostina M Fava, Zoran B Popovic, Alaa Alashi, et al.Current Treatment Options in Cardiovascular Medicine|September 2, 2019
Clinical Applications of Echo Strain Imaging: a Current AppraisalAgostina M Fava, Dane Meredith, Milind Y DesaiHeart (British Cardiac Society)|January 18, 2020
Advanced imaging for risk stratification of sudden death in hypertrophic cardiomyopathyJay Ramchand, Agostina M Fava, Michael Chetrit, et al.Expert Opinion on Biological Therapy|November 10, 2021
Rilonacept for the treatment of recurrent pericarditisAgostina M Fava, Reza Reyaldeen, Saberio Lo Presti, et al.The American Journal of Cardiology|August 2, 2024
Measurements of the Interventricular Septum and Mitral Leaflet Length in Hypertrophic Cardiomyopathy Patients Who Underwent Surgical Myectomy: A Prospective Comparative Multimodality Imaging StudyAgostina M Fava, Anand R Mehta, Andrew Bauer, et al.JACC. Cardiovascular Imaging|October 23, 2022
Quantitative Echocardiographic Assessment and Optimal Criteria for Early Intervention in Asymptomatic Tricuspid RegurgitationEmmanuel Akintoye, Tom Kai Ming Wang, Michael Nakhla, et al.The American Journal of Cardiology|May 19, 2016
Validation of the 2014 European Society of Cardiology Sudden Cardiac Death Risk Prediction Model in Hypertrophic Cardiomyopathy in a Reference Center in South AmericaAdrián Fernández, Alejandro Quiroga, Juan Pablo Ochoa, et al.Clinical and Experimental Medicine|April 20, 2022
Novel targeted C3 inhibitor pegcetacoplan for paroxysmal nocturnal hemoglobinuriaBo XuPageof 383